Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients

被引：0
|
作者：
Carlos Pérez-Ruixo
José E. Peris
Vanesa Escudero-Ortiz
Pedro Bretcha-Boix
José Farré-Alegre
Juan José Pérez-Ruixo
Belén Valenzuela
机构：
[1] University of Valencia,Pharmacy and Pharmaceutical Technology Department
[2] Hospital Quirón Torrevieja,Platform of Oncology
[3] AMGEN,Pharmacokinetics and Drug Metabolism
[4] UCAM Catholic University of San Antonio,Cathedra of Multidisciplinary Oncology
[5] Hospital Quiron Torrevieja,Personalized Pharmacotherapy Unit, Platform of Oncology
[6] Consulting Projects for Research,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Oxaliplatin bioavailability; Peritoneal carcinomatosis; Pharmacokinetics; NONMEM; Hyperthermic intraperitoneal chemotherapy; Cytoreductive surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1009 / 1020
页数：11
相关论文
共 50 条
  • [41] Gastrointestinal Cancers With Peritoneal Carcinomatosis: Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Loggie, Brian W.
    Thomas, Peter
    ONCOLOGY-NEW YORK, 2015, 29 (07): : 515 - 521
  • [42] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis
    Gammon, David C.
    Dutton, Traci
    Piperdi, Bilal
    Zybert, Jason
    Wolfe, Steven H.
    Nguyen, Erin
    Sbat, Dalia
    Pillarisetty, Venu G.
    Sullivan, Mary
    Whalen, Giles F.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (13) : 1186 - 1190
  • [43] Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations
    Joerg OW Pelz
    J Doerfer
    A Dimmler
    W Hohenberger
    T Meyer
    BMC Cancer, 6
  • [44] Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
    Alexander S. Martin
    Daniel E. Abbott
    Dennis Hanseman
    Jonathan E. Sussman
    Alexander Kenkel
    Parker Greiwe
    Noor Saeed
    Samar H. Ahmad
    Jeffrey J. Sussman
    Syed A. Ahmad
    Annals of Surgical Oncology, 2016, 23 : 1941 - 1947
  • [45] Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis
    Cashin, P. H.
    Ehrsson, H.
    Wallin, I.
    Nygren, P.
    Mahteme, H.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 533 - 540
  • [46] Hyperthermic intraperitoneal chemoperfusion is an option for treatment of peritoneal carcinomatosis in children
    Reingruber, Bertram
    Boettcher, M. I.
    Klein, P.
    Hohenberger, W.
    Peltz, J. O. W.
    JOURNAL OF PEDIATRIC SURGERY, 2007, 42 (09) : e17 - e21
  • [47] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly
    Tabrizian, P.
    Jibara, G.
    Shrager, B.
    Franssen, B.
    Yang, M.
    Sarpel, U.
    Hiotis, S.
    Labow, D.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S73 - S74
  • [48] Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for the Management of Advanced Peritoneal Carcinomatosis
    Halkia, Eleni A.
    Kyriazanos, John
    Efstathiou, Eleftherios
    Spiliotis, John D.
    HEPATO-GASTROENTEROLOGY, 2011, 58 (112) : 1915 - 1917
  • [49] Intraperitoneal hyperthermic chemotherapy as treatment of peritoneal carcinomatosis of colorectal cancer
    Markman, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) : 1527 - 1527
  • [50] Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model
    Klaver, Y. L. B.
    Hendriks, T.
    Lomme, R. M. L. M.
    Rutten, H. J. T.
    Bleichrodt, R. P.
    de Hingh, I. H. J. T.
    BRITISH JOURNAL OF SURGERY, 2010, 97 (12) : 1874 - 1880
12345